David O. Nettleton

A Combined Model for Predicting CYP3A4 Clinical Net Drug-Drug Interaction Based on CYP3A4 Inhibition, Inactivation, and Induction Determined in Vitro

Odette A. Fahmi, Tristan S. Maurer, Mary Kish et al. · Drug Metabolism and Disposition · 2008 · 198 citations

Medicinal Chemistry Profiling of Monocyclic 1,2‐Azaborines

Peng Zhao, David O. Nettleton, Rajeshri G. Karki et al. · ChemMedChem · 2017 · 114 citations · Full text

Glucose-Induced Conformational Changes in Glucokinase Mediate Allosteric Regulation:  Transient Kinetic Analysis

Vladi V. Heredia, J. D. Thomson, David O. Nettleton et al. · Biochemistry · 2006 · 87 citations

Glucose-induced Conformational Changes, Cellular Enzymology, Biochemistry +13

Predicting safety toleration of pharmaceutical chemical leads: Cytotoxicity correlations to exploratory toxicity studies☆

John W. Benbow, Jiri Aubrecht, Michael J. Banker et al. · Toxicology Letters · 2010 · 53 citations

Drug Safety, Pharmaceutical Chemical Leads, Medicinal Chemistry +8

Genetics of Bacillus subtilis chemotaxis: isolation and mapping of mutations and cloning of chemotaxis genes

George Ordal, David O. Nettleton, J A Hoch · Journal of Bacteriology · 1983 · 48 citations · Full text

Bacillus Subtilis Chemotaxis, Natural Sciences, Genetics +15